Literature DB >> 6981997

Estrogens and surgery in women with von Willebrand's disease.

J B Alperin.   

Abstract

While receiving estrogen therapy, three women with classic type I von Willebrand's disease showed significantly less bleeding and improved hemostasis. One took estrogens to prevent menopausal symptoms, and two used oral contraceptives. These women underwent major surgery without excessive bleeding and without requiring cryoprecipitate or other blood components. Prior to estrogen therapy, each woman had received cryoprecipitate or fresh frozen plasma to stop bleeding from dental extractions or other surgical procedures. Furthermore, two other women with type I von Willebrand's disease also exhibited improved hemostasis while taking oral contraceptives. These experiences suggest a short course of estrogen therapy may effectively prepare some women with von Willebrand's disease for elective surgery.

Entities:  

Keywords:  Biology; Bleeding; Contraception; Contraceptive Methods; Diseases; Endocrine System; Estrogens--therapeutic use; Family Planning; Hematoma; Hormones--therapeutic use; Oral Contraceptives; Physiology; Pregnancy; Reproduction; Surgery

Mesh:

Substances:

Year:  1982        PMID: 6981997

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  6 in total

Review 1.  Abnormal Uterine Bleeding in Young Women with Blood Disorders.

Authors:  Kathryn E Dickerson; Neethu M Menon; Ayesha Zia
Journal:  Pediatr Clin North Am       Date:  2018-06       Impact factor: 3.278

2.  A novel modifier gene for plasma von Willebrand factor level maps to distal mouse chromosome 11.

Authors:  K L Mohlke; W C Nichols; R J Westrick; E K Novak; K A Cooney; R T Swank; D Ginsburg
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-24       Impact factor: 11.205

3.  Von Willebrand Disease and Pregnancy.

Authors:  Muhammad Wasif Saif; Carmen Allegra
Journal:  Consultant       Date:  2001-03

4.  Desmopressin responsiveness by age in type 1 von Willebrand disease.

Authors:  Nicola Goldberg; Rosane Nisenbaum; Hong Song; David Lillicrap; Jerome Teitel; Paula James; Michelle Sholzberg
Journal:  Res Pract Thromb Haemost       Date:  2020-05-30

5.  Utility of a screening tool for haemostatic defects in a multicentre cohort of adolescents with heavy menstrual bleeding.

Authors:  Ayesha Zia; Joseph Stanek; Myra Christian-Rancy; Sanjay P Ahuja; Stephanie Savelli; Sarah H O'Brien
Journal:  Haemophilia       Date:  2018-09-12       Impact factor: 4.287

6.  Treatment of patients with von Willebrand disease.

Authors:  Emma Tuohy; Emma Litt; Raza Alikhan
Journal:  J Blood Med       Date:  2011-04-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.